The V(D)J recombination, which leads to the somatic rearrangement of variable, diversity, and joining segments, is the mechanism accountable for the diversity of T cell receptor-and Ig-encoding genes. The products of the RAG1 and RAG2 genes are the lymphoid-specific factors responsible for the initiation of the V(D)J recombination through the generation of a DNA double strand break. RAG1 or RAG2 gene inactivation in the mouse leads to abortion of the V(D)J rearrangement process, early block in both T and B cell maturation, and, ultimately, to severe combined immune deficiency (SCID). A human SCID condition is also characterized by an absence of mature T and B lymphocytes and is associated with mutations in either RAG1-or RAG2-encoding genes. Based on the predicted ␤-propeller three-dimensional structure model for RAG2, we found that six out of the seven mutations described to date in T-B-SCID patients are clustered on one side of the propeller, in regions exposed to solvent. This finding reinforces the biological significance of this predicted model and suggests that RAG1 interacts with RAG2 on one of the side of the scaffold formed by the ␤-propeller.
Immunoglobulin and T-cell receptor genes are composed of variable (V), 1 diversity (D), and joining (J) segments, which undergo somatic rearrangements prior to their expression. This process is completed by the V(D)J recombinase and can be roughly divided into two phases (reviewed in Ref. 1) . During the initial step, the lymphoid-specific proteins RAG1 and RAG2 recognize recombination-specific sequences that flank all V, D, and J gene segments and introduce a DNA double strand break at the border of the recombination-specific sequence (2, 3) . Subsequently, the general DNA repair machinery is recruited to resolve the double strand break and complete the V(D)J rearrangement (4) . The critical role of RAG1 and RAG2 has been first recognized from gene inactivation experiments in the mouse (5, 6) . The absence of either one results in an early block in both T and B cell maturation leading to severe combined immune deficiency (T-B-SCID). In humans, about 20% of SCID patients lack T and B lymphocytes but have normal natural killer cell counts (7) . These patients can be further divided into two groups. Some patients have been found to carry mutations in either the RAG1-or the RAG2-encoding genes, which compromise the early step of the V(D)J recombination (8) . Other patients are characterized by an increased radiosensitivity of their bone marrow cells and fibroblasts (RS-SCID) (9 -11) , supporting the hypothesis of a defect in the last step of the V(D)J recombination in one of the genes involved in DNA repair. Last, a residual activity of RAG1 or RAG2 caused by leaky mutations has been described in patients with Omenn syndrome (12) . This condition is characterized by an absence of circulating B cells but the presence of highly restricted and activated T lymphocytes that infiltrate the gut and the skin (13) .
The RAG1-and RAG2-encoding genes were cloned about 10 years ago, and many advances in the understanding of their function have been achieved recently through the development of nearly complete V(D)J reactions in vitro in acellular models (for a review, see Ref. 2) . Several important issues still remain unresolved, one of which is the respective role of RAG1 and RAG2 in the recombination reaction and the recognition of the catalytic site of the RAG1-RAG2 complex. The description of RAG1/RAG2 mutations resulting in the SCID phenotype in humans is of great value in trying to build structure-function relationships for these two proteins. We present here three new RAG2 mutations and show that six out of seven described RAG2 mutations in human SCID or Omenn patients are clustered in the same predicted three-dimensional region, thought to be involved in RAG1-RAG2 interaction.
EXPERIMENTAL PROCEDURES
Patients-Both patients (patients 10 and 41) analyzed in this study presented with a typical phenotype of autosomal recessive SCID with no circulating T cells and B cells, while natural killer cells were present. Patient 10, but not patient 41, originated from a consanguineous family. Informed consent was obtained from the patients' parents prior to this study.
RAG2 Gene Sequencing and Cloning-RAG2 coding sequence was amplified by polymerase chain reaction on genomic DNA obtained from whole blood using R2F1B 5Ј-CGGATCCATGTGAAGGAATCTAAATA and R2R1X 5Ј-GCTCTAGACTAAAAGAAAACATAGGCA primers and the Expand High Fidelity polymerase chain reaction system (Roche Molecular Biochemicals) according to the manufacturer's recommendations. Nucleotide primers were chosen on the HuRAG2 sequence from Ref. 14. Polymerase chain reaction products were directly sequenced using internal primers and the dRhodamine terminator cycle sequencing kit (ABI). For functional V(D)J recombination assays, polymerase chain reaction products were subcloned into pcDNA1.1 (Invitrogen) as BamHI-XbaI fragments. RAG2 expression constructs were rese-* This work was supported by institutional grants from Institut National de la Santé et de la Recherche Médicale and Ministère de l'Education Nationale de la Recherche et de la Technologie, and grants from Association de Recherche sur le Cancer (ARC), Association contre les myopathies (AFM), and Commissariat à l'Energie Atomique (CEA-LRC 7V). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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quenced to confirm the presence of the patient's mutation and the absence of Taq polymerase misincorporation.
Western Blot-Full-length RAG2 proteins are rapidly degraded during the cell cycle, making them difficult to detect by Western blot. To analyze the integrity of the RAG2 mutated proteins, core regions of wild type and mutant RAG2, which lack the specific degradation signal, were cloned into pmR2⌬C (a generous gift of E. Spanopoulou) in place of the murine RAG2 sequence. In this construct, the RAG2 core protein is fused to glutathione S-transferase and expressed under the control of the strong EF1␣ promoter. The expressed fusion protein was then detected using an anti-glutathione S-transferase antibody. These constructs were introduced into 293T cells by CaPO4 precipitation. 48 h following transfection, cells were lysed in 50 mM Tris (pH 7.5), 1% SDS, and the cellular extract was boiled for 5 min and clarified by centrifugation. 100 g of protein were loaded onto 12% SDS-polyacrylamide gel electrophoresis.
V(D)J Recombination Assay-The V(D)J recombination assay was carried out in fibroblasts as described previously (9) . Briefly, 5 ϫ 10 6 exponentially growing HeLa or SV40-transformed human fibroblasts were electroporated in 400 l of complete culture medium with 6 g of RAG1-and 4.8 g of RAG2-encoding plasmids, carrying either the wild type or mutated sequences, together with 2.5 g of either pHRecCJ (coding joint) or pHRecSJ (signal joint) V(D)J extrachromosomal substrates. These plasmids carry a lacZ gene interrupted by a stuffer DNA flanked by recombination-specific sequences. Upon V(D)J-mediated recombination, the stuffer DNA is excised, and the lacZ gene is reassembled. 48 h after transfection, extrachromosomal DNA was prepared by rapid alkaline lysis and used for transfection of DH10B bacteria. The percentage of recombination was determined by plating bacteria in the presence of X-gal and isopropyl-1-thio-␤-D-galactopyranoside and counting blue colonies relative to white colonies.
RAG2 Three-dimensional modeling-The model of the ␤-propeller structure for the first 350 amino acids of RAG2 has been previously described through "hydrophobic cluster analysis" and alignment of the RAG2 sequence repeats constituting the structural unit of the propeller with repeats belonging to the kelch family including those of the galactose oxidase (15) . The three-dimensional structure of the galactose oxidase has been experimentally determined (PDB:1GOF) and consists of a 7-fold symmetry ␤-propeller. However, in order to restore the 6-fold symmetry predicted for the RAG2 propeller, we used as template the six-bladed propeller of influenza A neuraminidase (Protein Data Bank code 1NCC; NRAM_IATRA), whose ␤-strands of each blade have been fitted on the predicted ␤-strand of RAG2. All modeling procedures were carried out using MODELLER4 (16) .
RESULTS AND DISCUSSION

Three Novel RAG2 Mutations in T-B-SCID Patients-Two
classes of T-B-SCID patients have been described that can be distinguished based on the affected step of the V(D)J recombination process. Genetic linkage analysis performed in the patient 10 family by using polymorphic markers surrounding the RAG1-RAG2 locus on human chromosome 11 was consistent with the possible existence of RAG1/RAG2 mutation in patient 10 (data not shown). Indeed, sequencing of the RAG2 coding region revealed a homozygous G1305T transversion leading to an R35V substitution. This mutation was found to be heterozygous in both parents (data not shown). The RAG2 gene was directly sequenced as a candidate gene in patient 41, originating from a nonconsanguineous family. Patient 41 carried two missense mutations in the RAG2 gene: an A1316G transversion causing an R39G amino acid substitution and a G1887A transversion leading to an R229E substitution. Interestingly, another replacement (Gln) of the same Arg 229 residue has been previously described in a T-B-SCID patient (8) . The RAG1 and RAG2 proteins are very well conserved through evolution, suggesting that any amino acid change may potentially compromise the activity of the resulting protein. However, one cannot formally rule out the possibility of silent mutations. The functionality of the three identified RAG2 mutants was therefore assessed in a fibroblast-based V(D)J recombination assay (9) . In this assay, a reporter construct consisting of the lacZ gene disrupted by a recombination-specific sequence-flanked stuffer DNA, is introduced into fibroblasts together with RAG1-and RAG2-expressing plasmids. If the reporter plasmid undergoes V(D)J recombination, the lacZ gene is reconstituted and can be monitored into bacteria upon plating on X-gal-containing plates. The number of blue colonies is then indicative of a successful recombination of the construct as shown for the wild type RAG2 construct in Table I . In contrast, the V(D)J recombinase activity was totally abolished when the three mutated forms of RAG2 were introduced, since virtually no blue colonies could be recovered in assays testing for the formation of either the coding joint (pHRecCJ) or the signal joint (pHRecSJ) ( Table  I ). The absence of V(D)J recombination activity was not due to a degradation of the mutant RAG2 proteins as shown by Western blot (Fig. 1) for R229E and R39G. This analysis confirmed that the three identified mutations are directly responsible for the SCID phenotype in the two patients studied here and brings to seven the number of described missense mutations in the RAG2 gene that lead to T-B-SCID or Omenn syndrome in humans.
Positions of RAG2 Mutations on the Predicted ␤-Propeller Three-dimensional Structure-The use of sensitive methods of sequence analysis, including the bidimensional hydrophobic cluster analysis, for the analysis of the RAG2 protein sequence revealed two distinct globular domains separated by a hinge region of 60 amino acids (15) . The largest domain encompasses the first 350 amino acid residues and covers the previously defined active core of RAG2. Further examination of the hydrophobic cluster analysis profile for this domain highlighted the existence of a 6-fold-repeated motif of about 50 amino acids, which was conserved in the RAG2 core from several species. Careful analysis of the sequence of the active core strongly suggested that the RAG2 repeats belong to the kelch family of motifs, which consist of several equivalent four-stranded ␤-sheets arranged in a circular way like blades of a propeller (␤-propeller structure). An approximate model for the structure of the predicted six-bladed ␤-propeller of RAG2 is presented in Fig. 2 , based on the previous alignment with the galactose oxidase (15) , a member of the kelch family whose structure has been experimentally determined (PDB:1GOF), and on further alignment with the six-bladed propeller of influenza A neuraminidase (PDB:1NCC) to restore the 6-fold symmetry as the ␤-propeller from the galactose oxidase contains seven blades. The six predicted blades are labeled a-f, according to the sequence progression, with blade f including the three C-terminal strands ␤ 1 , ␤ 2 , and ␤ 3 , and N-terminal strand ␤ 4 , thereby providing the circular closure of the blade arrangement. In Fig.  2B , a top representation is presented, whereas a 90°view is presented in Fig. 2C . One can see that each blade is made of four ␤-strands separated by loops of various lengths. The ␤-strands participate in the globular core of the propeller structure, while the loops, especially the 2.3 loops, extend outside of the structure and are exposed to solvent. Because of this particular structure, ␤-propellers are generally considered as general scaffold proteins with a conserved structural core and variable sequences on the outside loops. As such, these structures are widely involved in protein-protein interactions through the relatively flat surfaces they present on either side.
FIG. 2.
A, amino acid sequence of the six RAG2 ␤-propeller blades as determined through hydrophobic cluster analysis-deduced one-dimensional alignment with the galactose oxidase kelch-like repeat (15); only blocks 3, including strand ␤ 3 (whose predicted positions are underlined) and connecting loops 2.3 and 3.4 are represented. Mutated residues, located in loop 2.3 or within block 3 are in boldface type. B and C, ribbon representation of an approximate template for the RAG2 six-bladed ␤-propeller structure (amino acids 1-349; RAG2_HUMAN). The ␤-propeller is viewed along (B) or perpendicular to (C) its axis. Each blade of the propeller (labeled a-f; the b blade is circled) consists of a four-stranded ␤-sheet (␤-strands are labeled 1 (inner strand) to 4 (outer strand)). The sheets are organized in a circular formation like blades of a propeller or turbine. The closure of the turbine is achieved by a 1 ϩ 3 combination (N-terminal strand ␤ 4 and three C-terminal strands ␤ 1 to ␤ 3 ). Two wide surfaces (C) are provided on each side of the propeller by loops connecting strand ␤ 2 to ␤ 3 and ␤ 4 to ␤ 1 (top) on the one hand and strand ␤ 1 to ␤ 2 and ␤ 3 to ␤ 4 (bottom) on the other hand. Mutated amino acids, shown in a ball and stick representation, are located on the same side of the propeller. G35V, R39G, and R229E mutations are described here. The R229Q mutation is from Ref. Because of initial difficulties in detecting full-length RAG2 proteins, we chose to analyze the core region only of the two mutated forms of RAG2 from patient 41. These proteins were expressed at a high level into 293T cells as glutathione S-transferase (GST) fusion proteins and revealed by means of Western blot using an anti-glutathione S-transferase antibody. The fact that there was no change in the amount of protein detected by using the two mutants compared with the hR2⌬C and mR2⌬C attests to the integrity of the RAG2 proteins harboring these mutations.
We determined which regions of this predicted three-dimensional model of the core RAG2 harbored the various RAG2 mutations described to date (Fig. 2C) . Most surprisingly, six out of the seven identified mutations are located in the ␤-propeller structure of RAG2, clustered in the same area of the predicted three-dimensional model. Indeed, all of these mutations are present either at the very beginning of block 3, just before the position of the predicted strands ␤ 3 (C41W, R229Q, R229E, and M285R) or within the 2.3 loop linking strand ␤ 2 to strand ␤ 3 (G35V and R39G). The six mutations, which are localized on the region of the ␤-propeller structure exposed to solvent, on the same side of the scaffold, indicate that this region of the RAG2 protein is absolutely critical for functional activity. The C41W and M285R substitutions were previously found to significantly reduce the interaction between RAG1 and RAG2 in vitro (12) . As a possible consequence, these two mutants gave no detectable DNA binding activity of the RAG1-RAG2 complex (12) , which is consistent with the hypothesis of the role of RAG2 in stabilizing the complex (17) (18) (19) . According to the ␤-propeller predictive model, the Cys 41 and Met 285 residues, which are located quite far apart on the primary structure, are spatially arranged close to each other, which now makes it easier to conceive the biological significance of their modification. One cannot however formally exclude the possibility that these mutations compromise the function of RAG2 because of a general folding alteration of the protein rather than the modification of residues directly involved in RAG1-RAG2 interaction. Altogether, this predictive model and the positioned mutations found in T-B-SCID patients suggest that the ␤-propeller structure of RAG2 serves as a scaffold on one side of which the RAG1 protein interacts. According to this hypothesis, it is interesting to note the strikingly large length of the 2.3 loop c, suggesting that residues on this loop, protruding at the surface of the propeller, may directly interact with RAG1 amino acids and thus help to stabilize the interaction between the two proteins.
Although the crystal structure for RAG2 is not yet available, some of us and others have proposed a ␤-propeller structure for the core domain of RAG2 between amino acids 1 and 350, based on hydrophobic cluster analysis (15) and other computational methods (20) . This type of analysis proved to be very powerful in the past in predicting the three-dimensional structure of globular regions for many proteins whose sequences did not share, at first sight, any obvious similarities with other proteins, prior to access to definitive three-dimensional data through crystallization. The finding that six out of the seven RAG2 mutations described to date in T-B-SCID and Omenn patients are positioned on the same side of the beta-propeller model reinforces the biological significance of this predictive model. The extension of this type of analysis to other globular domains of RAG2 and RAG1 should help in deciphering the various functional domains of these two proteins as well as their respective roles in the V(D)J recombination process.
